NCT02094599 - A Study of the Abuse Potential of Dronabinol in Recreational Cannabinoid Users | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions

Drug Abuse, Medication

Interventions

DRUG

Dronabinol 10 mg

Dronabinol at a strength equivalent to 10 mg provided in capsules or as an oral solution in syringes.

DRUG

Dronabinol 30 mg

Dronabinol at a strength equivalent to 30 mg provided in capsules or as an oral solution in syringes.

DRUG

Placebo

Matching placebo provided in capsules or as an oral solution in syringes.

Trial Locations (1)

INC Research Toronto, Inc., Toronto